Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
- PMID: 33798472
- DOI: 10.1016/j.ccell.2021.03.004
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
Abstract
Metastasis is facilitated by the formation of a "premetastatic niche," which is fostered by primary tumor-derived factors. Colorectal cancer (CRC) metastasizes mainly to the liver. We show that the premetastatic niche in the liver is induced by bacteria dissemination from primary CRC. We report that tumor-resident bacteria Escherichia coli disrupt the gut vascular barrier (GVB), an anatomical structure controlling bacterial dissemination along the gut-liver axis, depending on the virulence regulator VirF. Upon GVB impairment, bacteria disseminate to the liver, boost the formation of a premetastatic niche, and favor the recruitment of metastatic cells. In training and validation cohorts of CRC patients, we find that the increased levels of PV-1, a marker of impaired GVB, is associated with liver bacteria dissemination and metachronous distant metastases. Thus, PV-1 is a prognostic marker for CRC distant recurrence and vascular impairment, leading to liver metastases.
Keywords: Escherichia coli; bacteria; colorectal cancer; gut vascular barrier; inflammatory monocytes; macrophages; metastases; neutrophils; premetastatic niche; vasculature.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment in
-
Bacteria prepare the niche.Nat Rev Cancer. 2021 Jun;21(6):342-343. doi: 10.1038/s41568-021-00361-1. Nat Rev Cancer. 2021. PMID: 33859397 No abstract available.
-
Bacteria break barrier to promote metastasis.Cancer Cell. 2021 May 10;39(5):598-600. doi: 10.1016/j.ccell.2021.03.009. Epub 2021 Apr 22. Cancer Cell. 2021. PMID: 33891891 Free PMC article.
-
Linking gut vascular barrier to CRC liver metastases.Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):368. doi: 10.1038/s41575-021-00458-w. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33911224 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
